Modulation of transgene expression in plants

US11473095B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11473095-B2
Application numberUS-202016856536-A
CountryUS
Kind codeB2
Filing dateApr 23, 2020
Priority dateOct 11, 2016
Publication dateOct 18, 2022
Grant dateOct 18, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.

First claim

Opening claim text (preview).

What is claimed is: 1. A nucleic acid expression cassette comprising a gene of interest, a plant promoter operably linked to the gene of interest, and a target site, wherein the target site comprises SEQ ID NO:4, for at least one sRNA molecule present in a dicot plant. 2. The expression cassette of claim 1 , wherein the gene of interest is an agronomic trait gene, an insect resistance gene, an herbicide tolerance gene, a non-coding RNA gene, or a selectable marker gene. 3. The expression cassette of claim 1 , wherein the target site is between about 21 and about 25 nucleotides in length. 4. The expression cassette of claim 1 , wherein the dicot plant is selected from the group consisting of Arabidopsis , soybean, rapeseed, cotton, and tobacco. 5. A transgenic plant cell comprising the expression cassette of claim 1 , wherein the gene of interest is heterologous to the plant cell, and wherein the at least one sRNA molecule is an endogenous sRNA of the plant cell. 6. The transgenic plant cell of claim 5 , wherein the endogenous sRNA is expressed in the plant in a tissue-specific, tissue-preferred, or cell type-specific manner. 7. A transgenic plant tissue, plant part, or plant, comprising the transgenic plant cell of claim 5 . 8. The transgenic plant tissue, plant part, or plant of claim 7 , wherein the endogenous sRNA is expressed predominantly in seed tissue. 9. The transgenic plant tissue, plant part, or plant of claim 8 , wherein the sRNA is SEQ ID NO:3. 10. The transgenic plant tissue, plant part, or plant of claim 9 , wherein the gene of interest is an herbicide tolerance gene, and wherein expression of the herbicide tolerance gene is downregulated in seed tissue. 11. The transgenic plant tissue, plant part, or plant of claim 7 , wherein the target site is modified for partial or complete downregulation of the gene of interest. 12. A method for producing a transgenic plant cell, the method comprising: providing a nucleic acid expression cassette comprising an herbicide tolerance gene, a plant promoter operably linked to the gene, and a target site, wherein the target site comprises SEQ ID NO:4, for at least one sRNA molecule; and transforming a plant cell with the expression cassette, wherein the plant cell expresses the sRNA. 13. The method of claim 12 , wherein the sRNA hybridizes to mRNA transcribed from the herbicide tolerance gene and thereby reduces the expression of the herbicide tolerance gene. 14. The method of claim 12 , wherein the sRNA is an endogenous sRNA that is expressed in the plant cell in a tissue-preferred, tissue-specific, or cell type-specific manner. 15. The method of claim 12 , wherein the sRNA is SEQ ID NO:3. 16. The method of claim 12 , wherein the sRNA is encoded by a polynucleotide that is operably linked to a non-constitutive promoter in the genome of the plant cell. 17. The method according to claim 16 , wherein the non-constitutive promoter is a tissue-preferred, tissue-specific, or cell type-specific. 18. The method according to claim 16 , wherein the non-constitutive promoter is a tissue-specific promoter. 19. The method according to claim 18 , wherein the tissue-specific promoter initiates transcription selectively in vegetative tissue. 20. A plant tissue comprising a plant cell produced by the method according to claim 12 . 21. A plant comprising the plant tissue of claim 20 . 22. A method for producing a transgenic plant cell, the method comprising: providing a nucleic acid expression cassette comprising a gene of interest and a target site of a sRNA molecule, wherein the target site comprises SEQ ID NO:4; providing a plant cell, wherein the sRNA is expressed predominantly in seed tissue; and transforming the plant cell with the expression cassette. 23. The method of claim 22 , wherein the sRNA is SEQ ID NO:3. 24. A method for inhibiting expression of a gene of interest in a plant, comprising growing a plant comprising a nucleic acid expression cassette comprising a gene of interest, a plant promoter operably linked to the gene of interest, and a target site, wherein the target site comprises SEQ ID NO:4, for at least one sRNA molecule present in the plant, wherein expression of the gene of interest is downregulated only in tissues where the sRNA molecule is expressed. 25. The method of claim 24 , wherein the gene of interest is an agronomic trait gene, an insect resistance gene, an herbicide tolerance gene, a non-coding RNA gene, or a selectable marker gene. 26. The method of claim 24 , wherein the plant is a dicot plant selected from the group consisting of soybean, canola, cotton, and tobacco. 27. The method of claim 24 , wherein the gene of interest is heterologous to the plant, and wherein the at least one sRNA molecule is an endogenous sRNA of the plant. 28. The method of claim 27 , wherein the endogenous sRNA is expressed predominantly in seed tissue. 29. The method of claim 28 , wherein the sRNA is SEQ ID NO:3.

Assignees

Inventors

Classifications

  • Seed-specific, e.g. embryo, endosperm · CPC title

  • for herbicide resistance · CPC title

  • Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

  • Vegetative tissue-specific promoters · CPC title

  • Genetically Modified [GMO] plants, e.g. transgenic plants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11473095B2 cover?
This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.
Who is the assignee on this patent?
Corteva Agriscience Llc
What technology area does this patent fall under?
Primary CPC classification C12N15/8218. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).